Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis
Systemic sclerosis and autoimmune myositis are both associated with decreased quality of life and increased mortality. Their prognosis and management largely depend on the disease subgroups. Indeed, systemic sclerosis is a heterogeneous disease, the two predominant forms of the disease being limited...
Main Authors: | Margherita Giannini, Benjamin Ellezam, Valérie Leclair, Frédéric Lefebvre, Yves Troyanov, Marie Hudson, Jean-Luc Senécal, Bernard Geny, Océane Landon-Cardinal, Alain Meyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.974078/full |
Similar Items
-
Inclusion body myositis and Sjögren’s syndrome: the association works both ways
by: Margherita Giannini, et al.
Published: (2022-10-01) -
The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis
by: Alexandre Moura dos Santos, et al.
Published: (2019-12-01) -
Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation
by: Alain Meyer, et al.
Published: (2018-04-01) -
Dysphagia as Isolated Manifestation of Jo-1 Associated Myositis?
by: Bendix Labeit, et al.
Published: (2019-07-01) -
Cutaneous manifestations in idiopathic inflammatory myopathies
by: Juan Sanz-Correa, et al.
Published: (2022-07-01)